Membrane sidedness of biosynthetic pathways involved in the production of lysophosphatidic acid

Advances in Enzyme Regulation

Volumn 39, Issue 1, 1999, Pages 275-284

  Le Balle, François ^a   Simon, Marie Françoise ^a   Meijer, Sandra ^a   Fourcade, Olivier ^a   Chap, Hugues ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; CALCIUM IONOPHORE; IONOPHORE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPID; PHOSPHOLIPASE A;

ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; BLOOD; BLOOD CLOTTING; CELL FRACTIONATION; CELL MEMBRANE; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFECT; ERYTHROCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; METABOLISM; MOUSE; MOUSE STRAIN; PHOSPHOLIPID METABOLISM; SMOOTH MUSCLE CONTRACTION; THROMBOCYTE; THROMBOCYTE ACTIVATION;

EID: 0032879835     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(98)00024-7     Document Type: Conference Paper

References (39)

1. W. H. MOOLENAAR, LPA: a novel lipid mediator with diverse biological actions, Trends Cell Biol. 4, 213-219 (1994).
2. W. H. MOOLENAAR, Lysophosphatidic acid: a multifunctional phospholipid messenger, J. Biol. Chem. 270, 12949-12952 (1995).
3. W. H. MOOLENAAR, Lysophosphatidic acid signalling, Curr. Opin. Cell Biol. 7, 203-210 (1995).
4. W. H. MOOLENAAR, O. KRANENBURG, F. R. POSTMA and G. C. M. ZONDAG, Lysophosphatidic acid: G-protein signalling and cellular responses, Curr. Opin. Cell Biol. 9, 168-173 (1997).
5. F. GAITS, J. P. SALLES and H. CHAP, Dual effect of lysophosphatidic acid on proliferation of glomerular mesangial cells, Kidney Int. 51, 1022-1027 (1997).
6. J. H. HECHT, J. A. WEINER, S. R. POST and J. CHUN, Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex, J. Cell Biol. 135, 1071-1083 (1996).
7. Z. GUO, K. LILIOM, D. J. FISCHER, I. C. BATHURST, L. D. TOMEI, M. C. KIEFER and G. TIGYI, Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes, Proc. Natl. Acad. Sci. USA 93, 14367-14372 (1996).
8. S. AN, M. A. DICKENS, T. BLEU, O. G. HALLMARK and E. J. GOETZL, Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid, Biochem. Biophys. Res. Commun. 231, 619-622 (1997).
9. G. MAUCO, H. CHAP, M. F. SIMON and L. DOUSTE-BLAZY, Phosphatidic and lysophosphatidic acid production in phospholipase C- and thrombin-treated platelets. Possible involvement of a platelet lipase, Biochimie 60, 653-661 (1978).
10. J. GERRARD and P. ROBINSON, Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin, Biochim. Biophys. Acta 1001, 282-285 (1989).
11. T. EICHHOLTZ, K. JALINK, I. FAHRENFORT and W. H. MOOLENAAR, The bioactive phospholipid lysophosphatidic acid is released from activated platelets, Biochem. J. 291, 677-680 (1993).
12. G. TIGYI and R. MILEDI, Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells, J. Biol. Chem. 267, 21360-21367 (1992).
13. K. A. SCHUMACHER, H. G. CLASSEN and M. SPÄTH, Platelet aggregation evoked in vitro and in vivo by phosphatidic acid and lysoderivatives: identity with substances in aged serum (DAS), Thromb. Haemost. 42, 631-640 (1979).
14. A. TOKUMURA, K. HARADA, K. FUKUZAWA and H. TSUKATANI, Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma, Biochim. Biophys. Acta 875, 31-38 (1986).
15. 1 HDL from human ovarian follicular fluid: evidence for the presence of a lipid core, Biochemistry 35, 1352-1357 (1996).
16. G. TIGYI, L. HONG, M. YAKUBU, H. PARFENOVA, M. SHIBATA and C. W. LEFFLER, Lysophosphatidic acid alters cerebrovascular reactivity in piglets, Am. J. Physiol. 268, H2048-H2055 (1995).
17. Y. XU, G. CASEY and G. B. MILLS, Effect of lysophospholipids on signaling in the human Jurkat T cell line, J. Cell. Physiol. 163, 441-450 (1995).
18. A. M. WESTERMANN, E. HAVIK, F. R. POSTMA, J. H. BEIJNEN, O. DALESIO, W. H. MOOLENAAR and S. RODENHUIS, Malignant effusions contain lysophosphatidic acid (LPA)-like activity, Ann. Oncol. 9, 437-442 (1998).
19. F. GAITS, O. FOURCADE, F. LE BALLE, G. GUEGUEN, B. GAIGE, A. GASSAMA-DIAGNE, J. FAUVEL, J. P. SALLES, G. MAUCO, M. F. SIMON and H. CHAP, Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis, FEBS Lett. 410, 54-58 (1997).
20. 2 and of lysophosphatidic acid synthesis, Advan. Enzyme Regul. 38, 99-107 (1998).
21. 2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells, Cell 80, 919-927 (1995).
22. R. F. A. ZWAAL and A. J. SCHROIT, Pathophysiologic implications of membrane phospholipid asymmetry in blood cells, Blood 89, 1121-1132 (1997).
23. H. J. CHAP, R. F. A. ZWAAL and L. L. M. VAN DEENEN, Action of highly purified phospholipases on blood platelets. Evidence for an asymmetric distribution of phospholipids in the surface membrane, Biochim. Biophys. Acta 467, 146-164 (1977).
24. E. G. BLIGH and W. J. DYER, A rapid method of total lipid extraction and purification, Can. J. Biochem. Physiol. 37, 911-918 (1959).
25. P. COMFURIUS, J. M. SENDEN, R. H. TILLY, A. J. SCHROIT, E. M. BEVERS and R. F. A. ZWAAL, Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase, Biochim. Biophys. Acta 1026, 153-160 (1990).
26. H. CHAP and L. DOUSTE-BLAZY, Réaction de libération plaquettaire induite par la phospholipase C, Eur. J. Biochem. 48, 351-355 (1974).
27. 2, J. Biol. Chem. 264, 5768-5775 (1989).
28. P. COMFURIUS, E. M. BEVERS and R. F. A. ZWAAL, Stimulation of prothrombinase activity of platelets and erythrocytes by sub-lytic treatment with phospholipase C from Clostridium welchii, Biochem. Biophys. Res. Commun. 117, 803-808 (1983).
29. 2 by an acylamino phospholipid does not alter arachidonate liberation, J. Lipid Mediator 11, 281-293 (1995).
30. Min-induced intestinal neoplasia, Cell 81, 957-966 (1995).
31. 2 gene in inbred mouse strains, J. Biol. Chem. 270, 22378-22385 (1995).
32. 1 acting on phosphatidic acid in porcine platelet membranes, J. Biol. Chem. 259, 5083-5086 (1984).
33. 2 specific for phosphatidic acid. A possible mechanism for the production of arachidonic acid in platelets, J. Biol. Chem. 256, 5399-5403 (1981).
34. 2+-mobilizing stimulus for fibroblasts. Evidence for an extracellular site of action, J. Biol. Chem. 265, 12232-12239 (1990).
35. J. WEST, C. K. TOMPKINS, N. BALANTAC, E. NUDELMAN, B. MEENGS, T. WHITE, S. BURSTEN, J. COLEMAN, A. KUMAR, J. W. SINGER and D. W. LEUNG, Cloning and expression of two human lysophosphatidic acid acyltransferase cDNAs that enhance cytokine-induced signaling responses in cells, DNA Cell Biol. 6, 691-701 (1997).
36. C. BERHARDT, P. W. GRAY and L. W. TJOELKER, Human lysophosphatidic acid acyltransferase. cDNA cloning, expression, and localization to chromosome 9q34.3, J. Biol. Chem. 272, 20299-20305 (1997).
37. A. C. STAMPS, M. A. ELMORE, M. E. MILL, K. KELLY, A. A. MAKDA and M. J. FINNEN, A human cDNA sequence with homology to non-mammalian lysophosphatidic acid acyltransferases, Biochem. J. 326, 455-461 (1997).
38. K. KUME and T. SHIMIZU, cDNA cloning and expression of murine 1-acyl-sn-glycerol-3-phosphate acyltransferase, Biochem. Biophys. Res. Commun. 237, 663-666 (1997).
39. B. AGUADO and R. D. CAMPBELL, Characterization of a human lysophosphatidic acid acyltransferase that is encoded by a gene located in the class III region of the human major histocompatibility complex, J. Biol. Chem. 273, 4096-4105 (1998).